Stoboclo savings card: as little as $0 a dose with commercial insurance

How to pay the least

Ask for the cash price

Stoboclo

Stoboclo is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Ask your pharmacy for Stoboclo’s cash price, and one or two other pharmacies too.
Stoboclo’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameStoboclo

Authorized genericdenosumab-bmwo

Regular genericdenosumab-bmwo

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone sold yet

Same as Stoboclo?

The original

–

Brand nameThe maker’s card

Celltrion CARES Co-pay Assistance Program

Savings card from Celltrion

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a dose

In the maker’s words

“Patients may pay as little as $0 for each dose of STOBOCLO…”

From the maker’s offer on celltrionconnect.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Stoboclo itself, from the same company, sold without the brand name, and usually for less. For now Stoboclo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Stoboclo is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Osteoporosis
Osteoporosis from steroid medicines (glucocorticoids)
Strengthening bones during hormone therapy for prostate cancer
Strengthening bones during breast cancer hormone therapy

What the FDA label says

Stoboclo is a RANK ligand (RANKL) inhibitor indicated for treatment:

of postmenopausal women with osteoporosis at high risk for fracture
to increase bone mass in men with osteoporosis at high risk for fracture
of glucocorticoid-induced osteoporosis in men and women at high risk for fracture
to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer
to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer

Source: the FDA label for Stoboclo (CELLTRION USA, Inc.), February 5, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/stoboclo/